Prevalence and Risk Factors of Strongyloides stercoralis in Haemodialysis in Cochabamba, Bolivia: A Cross-Sectional Study

dc.contributor.authorNicolas Tebib
dc.contributor.authorNathalie Tebib
dc.contributor.authorMauricio Paredes
dc.contributor.authorRosario Castro
dc.contributor.authorStéphanie Baggio
dc.contributor.authorMario Villarroel Torrico
dc.contributor.authorAmilcar Alejandro Flores Leon
dc.contributor.authorMaya Herbas Zamorano
dc.contributor.authorFrançois Chappuis
dc.contributor.authorLaurent Gétaz
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T20:47:29Z
dc.date.available2026-03-22T20:47:29Z
dc.date.issued2022
dc.description.abstractAbstract  Background: Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and kidney transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication. In this study, we aimed to estimate the prevalence and associated risk factors of S. stercoralis infection in patients on dialysis in Cochabamba, Bolivia. Methods: A cross-sectional study was carried out among patients undergoing haemodialysis in Cochabamba (elevation 2,500 metres, temperate climate), collecting information on socio-demographic, lifestyle, and clinical variables, and using one coproparasitological technique (the modified Baermann technique) and one serological (ELISA) test. Results: In total, 149 patients participated in the study (mean age = 51.4 years, 48.3% male). End-stage renal disease was predominantly (59%) of hypertensive and/or diabetic origin. The positive serological prevalence was 18.8% (95% CI: 13.3%–25.9%). Based on the sensitivity and specificity of the ELISA test, the estimate of the true prevalence was 15.1% (95% CI: 9.4%–20.7%). Stool samples of 105 patients (70.5%) showed a coproparasitological prevalence of 1.9% (95% CI: 0.52%–6.68%). No potential risk factors were significantly associated with S. stercoralis infection. Conclusions: We found a high prevalence of S. stercoralis in Bolivian patients undergoing haemodialysis in Cochabamba. We recommend presumptive antiparasitic treatment at regular intervals to avoid the potentially fatal complications of severe strongyloidiasis.
dc.identifier.doi10.21203/rs.3.rs-1830861/v1
dc.identifier.urihttps://doi.org/10.21203/rs.3.rs-1830861/v1
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/84088
dc.language.isoen
dc.publisherResearch Square (United States)
dc.relation.ispartofResearch Square (Research Square)
dc.sourceSpitalzentrum Centre hospitalier Biel- Bienne
dc.subjectStrongyloides stercoralis
dc.subjectStrongyloidiasis
dc.subjectMedicine
dc.subjectDialysis
dc.subjectSerology
dc.subjectRisk factor
dc.subjectInternal medicine
dc.subjectHemodialysis
dc.subjectCross-sectional study
dc.subjectTransplantation
dc.titlePrevalence and Risk Factors of Strongyloides stercoralis in Haemodialysis in Cochabamba, Bolivia: A Cross-Sectional Study
dc.typepreprint

Files